M. E. Lebsack
- Rheumatology top 5%
- Hematology top 10%
- Acute Myeloid Leukemia Research 1
-
- Antibiotic Resistance in Bacteria 2
- Pharmacology top 10%
- Antibiotics Pharmacokinetics and Efficacy 4
-
- Poisoning and overdose treatments 2
-
- Monoclonal and Polyclonal Antibodies Research 2
-
- Analytical Methods in Pharmaceuticals 2
-
- Cancer therapeutics and mechanisms 1
-
- Neutropenia and Cancer Infections 1
- Co-authors
- Janice L. LookabaughGary V. GordonG. CampionAbbe RubinRoberta HannaJoan Korth‐BradleyDonna SimcoeAllen J. Sedman
- Journals
- The Journal of Clinical Pharmacology (3 papers)Antimicrobial Agents and Chemotherapy (2 papers)Journal of Clinical Oncology (1 paper)
- Partner nations
- United StatesCanada
In The Last Decade
M. E. Lebsack
10 papers receiving 422 citations
Peers
Comparison fields: 5 of 70
- Rheumatology 188
- Hematology 105
- Molecular Medicine 29
- Pharmacology 93
- Immunology 111
Countries citing papers authored by M. E. Lebsack
This map shows the geographic impact of M. E. Lebsack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. E. Lebsack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. E. Lebsack more than expected).
Fields of papers citing papers by M. E. Lebsack
This network shows the impact of papers produced by M. E. Lebsack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. E. Lebsack. The network helps show where M. E. Lebsack may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M. E. Lebsack, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 117 | |
| 2 | Safety of FLT3 ligand in healthy volunteers | 1997 | 15 |
| 3 | 1996 | 196 | |
| 4 | 1996 | 9 | |
| 5 | 1993 | 5 | |
| 6 | 1992 | 2 | |
| 7 | 1992 | 25 | |
| 8 | 1991 | 2 | |
| 9 | 1989 | 85 | |
| 10 | 1988 | 5 |
About M. E. Lebsack
M. E. Lebsack is a scholar working on Molecular Medicine, Pharmacology, Pharmacology, Analytical Chemistry and Emergency Medicine, having authored 10 papers that have together received 461 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (4 papers), Poisoning and overdose treatments (2 papers), Antibiotic Resistance in Bacteria (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Analytical Methods in Pharmaceuticals (2 papers), Cancer therapeutics and mechanisms (1 paper), Acute Myeloid Leukemia Research (1 paper) and Neutropenia and Cancer Infections (1 paper). The work is most often cited by research in Rheumatology (188 citations), Hematology (105 citations), Molecular Medicine (29 citations), Pharmacology (93 citations) and Immunology (111 citations). M. E. Lebsack has collaborated with scholars based in United States and Canada. Frequent co-authors include Janice L. Lookabaugh, Gary V. Gordon, G. Campion, Abbe Rubin, Roberta Hanna, Joan Korth‐Bradley, Donna Simcoe, Allen J. Sedman, Jerome J. Schentag and Thaddeus H. Grasela. Their work appears in journals such as The Journal of Clinical Pharmacology, Antimicrobial Agents and Chemotherapy, Journal of Clinical Oncology, Annals of Pharmacotherapy and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.